Structure-activity relationship studies of flavopiridol analogues

Bioorganic and Medicinal Chemistry Letters

Volumn 10, Issue 10, 2000, Pages 1037-1041

  Murthi, Krishna K ^a   Dubay, Marja ^a   McClure, Christopher ^a   Brizuela, Leonardo ^a   Boisclair, Michael D ^a   Worland, Peter J ^a   Mansuri, Muzammil M ^a   Pal, Kollol ^a  

^a GPC Biotech Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKENE DERIVATIVE; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 4; FLAVOPIRIDOL; ISOCOUMARIN DERIVATIVE; QUINOLONE DERIVATIVE;

ARTICLE; CELL CYCLE; CHEMICAL MODIFICATION; DRUG SCREENING; DRUG STRUCTURE; ENZYME INHIBITION; HUMAN; HUMAN CELL; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CHROMONES; CYCLIN-DEPENDENT KINASES; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME INHIBITORS; FLAVONOIDS; PIPERIDINES; PYRIDINES; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0034657527     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(00)00156-6     Document Type: Article

References (28)

1. Sherr, C. J. Cell 1994, 79, 551.
2. (b) Hunter, T.; Pines, J. Cell 1994, 79, 573.
3. (c) Morgan, D. O. Nature 1995, 374, 131.
4. (d) Draetta, G. F. Trends Biochem. Sci. 1990, 15, 378.
5. (e) Sherr, C. J. Cell 1993, 73, 1059.
6. Draetta G.F. Curr. Opin. Cell Biol. 6:1995;842.
7. (a) Harper, J. W. In Checkpoint Controls and Cancer; Kastan, M. B. Ed.; ICRF, 1997, pp 91-107.
8. (b) Serrano M. Hannon, G. J. Beach, D. Nature 1993, 366, 704.
9. Serrano M. Exp Cell Res. 237:1997;7.
10. (a) Czech, J.; Hoffmann, D.; Naik, R.; Sedlacek, H. H. Int. J. Oncol. 1995, 6, 31.
11. (b) Sedlacek, H. H., Hoffmann, D.; Czech, J.; Kolar, C.; Seeman, G.; Gussow, D.; Bosslet, K. Chimia 1991, 45, 311.
12. (a) Kaur, G.; Stetler-Stevenson, M.; Sebers, S.; Worland, P.; Sedlacek, H.; Myers, C.; Czech, J.; Naik, R.; Sausville, E. J. Natl. Cancer Inst. 1992, 84, 1736.
13. (b) Losiewiecz, M. D.; Carlson, B. A.; Kaur, G.; Worland, P. J. Biochem. Biophy. Res. Commun. 1994, 201, 589.
14. (c) Carlson, B. A.; Dubay, M. M.; Sausville, E. A.; Brizuela, L.; Worland, P. J. Cancer Res. 1996, 56, 2973.
15. (a) Senderowicz, A. M.; Headlee, D.; Stinson, S. F.; Lush, R. M.; Kalil, N.; Villalba, L.; Hill, K.; Steinberg, S. M.; Figg, W. D.; Tompkins, A.; Arbuck, S. G.; Sausville, E. A.; J. Clin. Oncol. 1998, 16, 2986.
16. (b) Wright, J.; Blatner, G. L.; Cheson, B.D., Oncology 1998, 12, 1018.
17. (c) Wright, J.; Blatner, G. L.; Cheson, B. D. Oncology, 1998, 12, 1023.
18. Sedlacek H., Czech J., Naik R., Kaur G., Worland P.J., Losiewiecz M.D., Parker B., Carlson B.A., Smith A., Senderowicz A., Sausville E.A. Intl. J. Oncol. 9:1996;1143.
19. Azevedo W.F., Mueller-Dieckmann H.J., Schulze-Gahmen U., Worland P.J., Sausville E.A., Kim S.H. Proc. Natl. Acad. Sci. USA. 93:1996;2735.
20. (a) Kattige, S. L.; Naik, R. G.; Lakdawalla, A. D.; Dohadwalla, A. N.; Rupp, R. H.; Desouza, N. J. U.S. Patent 4 900 727, 1990.
21. (b) Naik, R.; Lal, B.; Rupp, R. H.; Sedlacek, H. H.; Dickneite, G.; Czech, J. U.S. Patent 5 284 856, 1988.
22. (c) Naik, R.; Lal, B.; Rupp, R. H.; Sedlacek, H. H.; Dickneite, G.; Czech, J. Euro. Patent 0 366 061 1988.
23. (d) Naik, R.; Kattige, S. I.; Bhat, S. V.; Alrejy, B.; DeSouza, N. J.; Rupp, R. H. Tetrahedron 1988, 44, 2081.
24. Chang C.J., Geahlen R.L. J. Natl. Prod. 55:1992;1529.
25. Kuo S.C., Lee H.Z., Juang J.P., Lin Y.T., Wu T.S., Chang J.J., Lednicer D., Paul K.D., Lin C.M., Hamel E., Lee K.H. J. Med. Chem. 36:1993;1146.
26. Vinyl stannane 48 was prepared as shown below.
27. Ohta S., Kamata Y., Inagaki T., Masuda Y., Yamamoto S., Yamashita M., Kawasaki I. Chem. Pharm. Bull. 41:1993;1188.
28. Wick S.T., Dubay M.M., Imanil I., Brizuela L. Oncogene. 11:1995;2013.